H-1B sponsorship profile: Ny Drugs, Inc. Across U.S. Department of Labor LCA disclosures, Ny Drugs, Inc filed 6 Labor Condition Applications covering 6 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (6 certified of 6 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Ny Drugs, Inc’s H-1B petitions range from $70,658 at the low end to $151,840 at the high end, with a petition-weighted average of $84,705. That range reflects the mix of occupations the company sponsors, led by DATABASE ADMINISTRATOR (4 petitions at $70,658 avg), followed by REGULATORY AND COMPLIANCE ANALYST and Pharmacist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Ny Drugs, Inc is headquartered in BRONX, NY under NAICS code 446110, and places H-1B workers across 1 state, most heavily in NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Ny Drugs, Inc ranks. By H-1B petition volume, Ny Drugs, Inc is #23,486 of 119,880 employers nationally and #2,151 of 14,719 employers headquartered in NY. Both ranks are computed live from the same underlying petition counts, not a separate estimate.